You are here: Home » News-CM » Equities » Hot Pursuit
Business Standard

Cipla moves higher after receiving EIR for Indore facility

Capital Market 

rose 2.32% to Rs 594 at 9:43 on after the company said it has received Establishment Inspection Report from the US drug regulator for its Indore facility indicating formal closure of inspection conducted in July/August 2015.

The announcement was made on Wednesday, 12 October 2016. The stock market was closed on that day on account of Muharram.

Meanwhile, the S&P Sensex was down 228.69 points or 0.81% at 27,853.65.

On BSE, so far 96,000 shares were traded in the counter as against average daily volume of 2.06 lakh shares in the past one quarter. The stock hit a high of Rs 598.90 and a low of Rs 591 so far during the day. The stock had hit a 52-week high of Rs 704.75 on 29 October 2015. The stock had hit a 52-week low of Rs 458.25 on 25 May 2016. The stock had outperformed the market over the past one month till 10 October 2016, sliding 0.16% compared with 2.48% fall in the Sensex. The scrip had also outperformed the market in past one quarter, advancing 11.7% as against Sensex's 3.52% rise.

The large-cap company has equity capital of Rs 160.84 crore. Face value per share is Rs 2.

On a consolidated basis, reported 43.7% fall in net profit to Rs 365.24 crore on 6.9% decline in net sales to Rs 3499.81 crore in Q1 June 2016 over Q1 June 2015.

is a global pharmaceutical company.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU

Cipla moves higher after receiving EIR for Indore facility

Cipla rose 2.32% to Rs 594 at 9:43 IST on BSE after the company said it has received Establishment Inspection Report from the US drug regulator for its Indore facility indicating formal closure of inspection conducted in July/August 2015.

rose 2.32% to Rs 594 at 9:43 on after the company said it has received Establishment Inspection Report from the US drug regulator for its Indore facility indicating formal closure of inspection conducted in July/August 2015.

The announcement was made on Wednesday, 12 October 2016. The stock market was closed on that day on account of Muharram.

Meanwhile, the S&P Sensex was down 228.69 points or 0.81% at 27,853.65.

On BSE, so far 96,000 shares were traded in the counter as against average daily volume of 2.06 lakh shares in the past one quarter. The stock hit a high of Rs 598.90 and a low of Rs 591 so far during the day. The stock had hit a 52-week high of Rs 704.75 on 29 October 2015. The stock had hit a 52-week low of Rs 458.25 on 25 May 2016. The stock had outperformed the market over the past one month till 10 October 2016, sliding 0.16% compared with 2.48% fall in the Sensex. The scrip had also outperformed the market in past one quarter, advancing 11.7% as against Sensex's 3.52% rise.

The large-cap company has equity capital of Rs 160.84 crore. Face value per share is Rs 2.

On a consolidated basis, reported 43.7% fall in net profit to Rs 365.24 crore on 6.9% decline in net sales to Rs 3499.81 crore in Q1 June 2016 over Q1 June 2015.

is a global pharmaceutical company.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Cipla moves higher after receiving EIR for Indore facility

rose 2.32% to Rs 594 at 9:43 on after the company said it has received Establishment Inspection Report from the US drug regulator for its Indore facility indicating formal closure of inspection conducted in July/August 2015.

The announcement was made on Wednesday, 12 October 2016. The stock market was closed on that day on account of Muharram.

Meanwhile, the S&P Sensex was down 228.69 points or 0.81% at 27,853.65.

On BSE, so far 96,000 shares were traded in the counter as against average daily volume of 2.06 lakh shares in the past one quarter. The stock hit a high of Rs 598.90 and a low of Rs 591 so far during the day. The stock had hit a 52-week high of Rs 704.75 on 29 October 2015. The stock had hit a 52-week low of Rs 458.25 on 25 May 2016. The stock had outperformed the market over the past one month till 10 October 2016, sliding 0.16% compared with 2.48% fall in the Sensex. The scrip had also outperformed the market in past one quarter, advancing 11.7% as against Sensex's 3.52% rise.

The large-cap company has equity capital of Rs 160.84 crore. Face value per share is Rs 2.

On a consolidated basis, reported 43.7% fall in net profit to Rs 365.24 crore on 6.9% decline in net sales to Rs 3499.81 crore in Q1 June 2016 over Q1 June 2015.

is a global pharmaceutical company.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard